Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis-Reference-Cited by-同舟云学术

Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis

Published:2003-10-16 Issue:9 Volume:32 Page:915-923
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Forrest D L,Nevill T J,Naiman S C,Le A,Brockington D A,Barnett M J,Lavoie J C,Nantel S H,Song K W,Shepherd J D,Sutherland H J,Toze C L,Davis J H,Hogge D E

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1704243.pdf

Reference52 articles.

1. Clift RA, Appelbaum FR, Thomas ED . Treatment of chronic myeloid leukemia by marrow transplantation. Blood 1993; 82: 1954–1956.

2. Cassileth PA, Harrington DP, Appelbaum FR et al. Chemo-therapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med 1998; 339: 1649–1700.

3. Peters WP, Ross M, Vredenburgh JJ et al. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 1993; 11: 1132–1143.

4. Reece DE, Connors JM, Spinelli JJ et al. Intensive therapy with cyclophosphamide, carmustine, etoposide±cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy. Blood 1994; 83: 1193–1199.

5. Barnett MJ, Coppin CML, Murray N et al. High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours. Br J Cancer 1993; 68: 594–598.

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Re-examining the role of hematopoietic stem cell transplantation in relapsed large B-cell lymphoma in the era of chimeric antigen receptor (CAR) T-cell therapy;Frontiers in Oncology;2024-08-15

2. The HSCT procedure (II): Conditioning, hematopoietic stem cell infusion, supportive care, and monitoring;Handbook of Clinical Neurology;2024

3. Tandem High-dose Chemotherapy Increases the Risk of Secondary Malignant Neoplasm in Pediatric Solid Tumors;Cancer Research and Treatment;2023-11-24

4. Second primary malignancies in non-Hodgkin lymphoma: epidemiology and risk factors;Annals of Hematology;2023-01-09

5. Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma;Journal of Clinical and Experimental Hematopathology;2023